Plain-English translation of NCT06696079 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
If you have atrial fibrillation (irregular heartbeat), you likely take an oral anticoagulation medication to prevent blood clots and stroke. This trial is testing the best time to restart that medication after you have surgery to drain a chronic subdural hematoma—a collection of blood on the brain. Researchers want to know whether restarting the medication after 5 days is safer and more effective than waiting 30 days.
People with atrial fibrillation face a difficult choice after brain surgery: waiting too long to restart the medication increases the risk of stroke, but restarting too early increases the risk of bleeding. This trial aims to find the safest timing to protect both the brain and the heart.
You likely qualify if…
You likely don't qualify if…
After your brain surgery, you will be randomly assigned to restart your blood-thinning medication either 5 days or 30 days after the procedure. You will then be followed up for 3 months with visits and assessments to check for complications like bleeding, blood clots, and your overall recovery. The study team will monitor your health and ask about any symptoms or concerns during this time.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Finland